RxDoctor Payments Data

Michael Perini, MD

Internal Medicine · Midlothian, VANPI 1841238045

Payments from drug & device makers

$2,018in general payments, 2019–2025

Across 113 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$513
  • AstraZeneca$188
  • Novo Nordisk$185
  • Pfizer$168
  • Lilly USA, LLC$107
  • Vanda Pharmaceuticals Inc.$104
  • plus $753 from 22 others

What the payments were for

  • Food & beverage$2,018100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,018 in reported general payments places this provider in the 80th percentile of 2,724 internal medicine providers in Virginia.

See all internal medicine providers in Virginia

Medicare billing

Part B allowed, 2024
$193,890
Medicare patients
214
Services billed
3,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban27$12,589
JardianceEmpagliflozin13$11,739
BrilintaTicagrelor12$2,913
Leflunomide14$2,020
Bumetanide16$859
Quetiapine Fumarate50$857
Albuterol Sulfate HfaAlbuterol Sulfate23$723
Gabapentin45$634
Pantoprazole Sodium40$523
Atorvastatin Calcium40$521
Amlodipine Besylate66$461
Finasteride22$422
Levothyroxine Sodium52$362
Spironolactone33$360
Metformin Hcl46$337

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$168$12,58927 claims
Boehringer IngelheimJardiance$16$11,73913 claims
AstraZenecaBrilinta$188$2,91312 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$13$36252 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 internal medicine providers in Virginia.

Other internal medicine in Midlothian

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →